Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

#stocks #bullish #buys #analysts #research #WallStreet

$ALB $LTHM $RPRX $TRIP

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below are our Buy calls for Tuesday, 10 November, as follows:

Albemarle Corp. (NYSE:ALB) was raised to Buy from Neutral with a 132 price target at Citigroup.

Livent Corp. (NYSE:LTHM) was raised to Buy from Neutral with a 16.50 price target at Citigroup.

Royalty Pharma PLC (NASDAQ:RPRX) was raised to Buy from Neutral with a 51 target price at UBS. The stock has a 52.29 consensus price target.

Tapestry Inc. (NYSE:TPR): this retailer has staged a huge recovery amid the coronavirus chaos. Shares have a consensus price target of 26.71.

TripAdvisor Inc. (NASDAQ:TRIP)Needham maintained its Buy rating but lowered its price target to 25 from 26

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.